Abstract:The Tumor Microenvironment (TME) is characterized by low pH, hypoxia, and overexpression of glutathione (GSH). Owing to the complexity of tumor pathogenesis and the heterogeneity of the TME, achieving satisfactory efficacy with a single treatment method is difficult, which significantly impedes tumor treatment. In this study, composite nanoparticles of calcium-copper/alginate-hyaluronic acid (CaO2-CuO2@SA/HA NC) with pH and GSH responsiveness were prepared for the first time through a one-step synthesis using hyaluronic acid (HA) as a targeting ligand. Nanoparticles loaded with H2O2 can enhance the ChemoDynamic Therapy (CDT) effects. Simultaneously, Cu2+ can generate oxygen in the TME and alleviate hypoxia in tumor tissue. Cu2+ and H2O2 undergo the Fenton reaction to produce cytotoxic hydroxyl radicals and Ca2+ ions, which enhance the localization and clearance of nanoparticles in tumor cells. Additionally, HA and sodium alginate (SA) were utilized to improve the targeting and biocompatibility of the nanoparticles. FTIR, XRD, DLS, SEM, TEM, and other analytical methods were used to investigate their physical and chemical properties. The results indicate that the CaO2-CuO2@SA/HA NC prepared using a one-step method had a particle size of 220 nm, a narrow particle size distribution, and a uniform morphology. The hydrogen peroxide self-supplied nanodrug delivery system exhibited excellent pH-responsive release performance and glutathione-responsive •OH release ability while also reducing the level of reactive oxide species (ROS) quenching. In vitro cell experiments, no obvious side effects on normal tissues were observed; however, the inhibition rate of malignant tumors HepG2 and DU145 exceeded 50%. The preparation of CaO2-CuO2@SA/HA NC nanoparticles, which can achieve both chemokinetic therapy and ion interference therapy, has demonstrated significant potential for clinical applications in cancer therapy.

Liquid Nanoparticles for Nanocatalytic Cancer Therapy

Tumor-specific nanomedicine via sequential catalytic reactions for accurate tumor therapy.

Nanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme-Catalyzed Cascade Reaction

Self-supply of hydrogen peroxide by a bimetal-based nanocatalytic platform to enhance chemodynamic therapy for tumor treatment

Metabolism-Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy

Regulation of Interstitial Fluid Pressure for Improved Intratumor Drug Permeability and Nanozyme-Enhanced Chemocatalytic Therapy

Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H<sub>2</sub>O<sub>2</sub> for Catalytic Cascade-Amplified Tumor Therapy

A Procedurally Activatable Nanoplatform for Chemo/chemodynamic Synergistic Therapy

Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H2O2 for Catalytic Cascade-Amplified Tumor Therapy

Photothermo‐Promoted Nanocatalysis Combined with H2S‐Mediated Respiration Inhibition for Efficient Cancer Therapy

Dual Size/Charge‐Switchable Nanocatalytic Medicine for Deep Tumor Therapy

Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery

Tumor-selective catalytic nanomedicine by nanocatalyst delivery

Glutathione- and Ph-Responsive Nonporous Silica Prodrug Nanoparticles for Controlled Release and Cancer Therapy

Synergistic therapeutic effect of nanomotors triggered by Near-infrared light and acidic conditions of tumor

Tumor-Targeted Disruption of Lactate Transport with Reactivity-Reversible Nanocatalysts to Amplify Oxidative Damage

pH-Sensitive and Redox-Responsive Poly(Tetraethylene Glycol) Nanoparticle-Based Platform for Cancer Treatment

Dual Intratumoral Redox/Enzyme-Responsive NO-Releasing Nanomedicine for the Specific, High-Efficacy, and Low-Toxic Cancer Therapy.

Peroxidase-like Active Nanomedicine with Dual Glutathione Depletion Property to Restore Oxaliplatin Chemosensitivity and Promote Programmed Cell Death

Tumor-Microenvironment-Activated NIR-II Nanotheranostic Platform for Precise Diagnosis and Treatment of Colon Cancer